You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoma, T-Cell, Cutaneous

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Squamous Cell Carcinoma Trial in Suzhou (Sintilimab + chemo)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Sintilimab + chemotherapy
  • Suzhou, Jiangsu, China
    The first affiliated hospital of soochow university
Dec 13, 2021

Type 1 Diabetes Trial in Idaho Falls, Seattle (Liraglutide, Golimumab)

Completed
  • Type 1 Diabetes Mellitus
  • Idaho Falls, Idaho
  • +1 more
Jan 21, 2022

NSCLC Trial in Lausanne (Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine), Low dose

Recruiting
  • Non-small Cell Lung Cancer
  • Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine)
  • Low dose cyclophosphamide
  • Lausanne, Vaud, Switzerland
    CHUV Oncology Department
Jan 17, 2022

Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Australia, United States (ABT-199)

Completed
  • Chronic Lymphocytic Leukemia
  • Non-Hodgkin Lymphoma
  • Tucson, Arizona
  • +9 more
Feb 10, 2022

Warts, Warts Hand, Verruca Trial in United States (CellFX Device)

Completed
  • Warts
  • +2 more
  • CellFX Device
  • Scottsdale, Arizona
  • +4 more
Sep 12, 2020

Recurrent Pregnancy Loss Trial in Maastricht, Nijmegen (Exercise)

Recruiting
  • Recurrent Pregnancy Loss
  • Exercise
  • Maastricht, Netherlands
  • +1 more
Aug 22, 2023

Isocitrate Dehydrogenase Gene Mutation Trial in Spain, United States (HMPL-306)

Recruiting
  • Isocitrate Dehydrogenase Gene Mutation
  • Atlanta, Georgia
  • +6 more
Feb 22, 2022

Esophageal Squamous Cell Carcinomas Trial in Beijing (SI-B001, Irinotecan)

Recruiting
  • Esophageal Squamous Cell Carcinomas
  • Beijing, Beijing, China
    Beijing Cancer Hostital
Mar 14, 2022

Renal Cancer, Kidney Cancer, Renal Cell Carcinoma Trial in Aurora (Axitinib, Pembrolizumab)

Not yet recruiting
  • Renal Cancer
  • +3 more
  • Aurora, Colorado
    University of Colorado Cancer Center
Jul 24, 2023

Carcinoma, Renal Cell Trial in Dallas (Fitbit Versa)

Terminated
  • Carcinoma, Renal Cell
  • Fitbit Versa
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Feb 21, 2022

Survivors of Transplant, CREST Study

Recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Bioelectric Impedance Analysis
  • +7 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Mar 7, 2022

Olanzapine, CINV, Testicular Cancer by AJCC V6 and V7 Stage Trial in Guangzhou (Olanzapine Tablets, Placebo)

Recruiting
  • Olanzapine
  • +3 more
  • Olanzapine Tablets
  • Placebo
  • Guangzhou, Guangdong, China
    Sun Yat-sen University
Feb 14, 2022

Spinal Cord Injuries Trial in Salvador (Mesenchymal stem cell transplantation, Placebo)

Not yet recruiting
  • Spinal Cord Injuries
  • Mesenchymal stem cell transplantation
  • Placebo
  • Salvador, Bahia, Brazil
    Senai Cimatec
Jan 10, 2023

Diffuse Cutaneous Systemic Sclerosis Trial in Canada, United Kingdom, United States (Abatacept, Placebo)

Completed
Has Results
  • Diffuse Cutaneous Systemic Sclerosis
  • Los Angeles, California
  • +26 more
Feb 13, 2020

Patients With Restenosis of Calcified Lesions

Recruiting
  • Coronary Artery Calcification
  • +3 more
  • Coronary artery calcification lesions
  • Shenyang, Liaoning, China
    ShenyangNH
Jul 14, 2022

Pathophysiology of Anemia in PICU Survivors

Recruiting
  • Anemia
    • MontrĂ©al, Quebec, Canada
      Hopital Ste-Justine
    Jan 12, 2023

    Sickle Cell Disease, Sickle Cell Anemia Trial in United States (Hydroxyurea)

    Recruiting
    • Sickle Cell Disease
    • Sickle Cell Anemia
    • Phoenix, Arizona
    • +13 more
    Dec 7, 2021

    Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer Trial in Singapore (Oral lenvatinib + Intravenous (IV)

    Not yet recruiting
    • Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
    • Oral lenvatinib + Intravenous (IV) pembrolizumab + Oral letrozole
    • Singapore, Singapore
      National Cancer Centre Singapore
    Oct 13, 2022

    Observational Study About Patients Diagnosed With NAFLD

    Recruiting
    • Nonalcoholic Fatty Liver Disease
      • Changsha, Hunan, China
        Department of Infectious Disease, Xiangya Hospital, Central Sout
      Nov 25, 2022

      Lung Cancer Trial in Worldwide (osimertinib)

      Active, not recruiting
      • Lung Cancer
      • Aarhus, Denmark
      • +9 more
      Apr 6, 2022

      Non Small Cell Lung Cancer, Non-squamous Non-small-cell Lung Cancer, Urothelial Carcinoma Trial in Augusta (Cabozantinib,

      Recruiting
      • Non Small Cell Lung Cancer
      • +3 more
      • Augusta, Georgia
        Augusta University Georgia Cancer Center
      Mar 6, 2022

      COPD (COPD) Trial (Benralizumab, Benralizumab , Comparison (control) group; no intervention)

      Not yet recruiting
      • Chronic Obstructive Pulmonary Disease (COPD)
      • (no location specified)
      Apr 26, 2022

      Penile Cancer, Margin Assessment Trial in Groningen (Cetuximab-IRDye800CW)

      Recruiting
      • Penile Cancer
      • Margin Assessment
      • Groningen, Netherlands
        University Medical Center Groningen
      May 16, 2022

      Acute Lymphoblastic Leukemia Trial in United States (ADCT-402)

      Terminated
      Has Results
      • Acute Lymphoblastic Leukemia
      • La Jolla, California
      • +9 more
      Apr 27, 2021

      Poliomyelitis Trial in Gao'an, Pingxiang (sIPV vaccine /DTaP vaccine, sIPV vaccine /Hepatitis A inactivated vaccine /MMR

      Recruiting
      • Poliomyelitis
      • sIPV vaccine /DTaP vaccine
      • sIPV vaccine /Hepatitis A inactivated vaccine /MMR vaccine
      • Gao'an, Jiangxi, China
      • +1 more
      Jun 20, 2022